Maravai LifeSciences Holdings, Inc.
- MRVI
- NASDAQ
- Biotechnology
- Life Sciences Reagents
- Nucleic Acid Products (mRNA/cDNA)
$6.95
Today +2.42%Quote Oct 19, 2026, 05:00 PM UTC
−6.60%over the last month
Max drawdown −23.4%From 1-month high −20.3%3 months −2.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Maravai LifeSciences
Maravai LifeSciences Holdings, Inc. is a life sciences company operating globally, supplying essential products that facilitate the advancement of drug therapies, diagnostics, innovative vaccines, and research into human diseases.
Where the money comes from
Q1 2026 revenue $65.8M
- Nucleic Acid Production Segment$47.5M72.1%
- Biologics Safety Testing Segment$18.4M27.9%
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
415
Founded
2020
Market value
$1.03B
Approximate share count
Floor
$6.72
3.4% below price
Resistance
$7.33
5.4% above price
Price vs analyst targets
14 analysts
Lowest target
$6.00Highest target
$8.00
$6.00Highest target
$8.00
- Price $6.95
- Average target $7.00
- Analysts' target range
Analysts' average target sits about 1% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about MRVIPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free